Holen Sie sich die Stockscreener-App
8.19
12.04%
0.88
Vorhandelsmarkt:
7.53
-0.66
-8.06%
Schlusskurs vom Vortag:
$7.31
Offen:
$7.36
24-Stunden-Volumen:
71,295
Relative Volume:
0.19
Marktkapitalisierung:
$12.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-1.575
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
+17.17%
1M Leistung:
+695.15%
6M Leistung:
+309.50%
1J Leistung:
+90.47%
1-Tages-Spanne:
$7.35
$8.23
1-Wochen-Bereich:
$7.01
$9.09
52-Wochen-Spanne:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Firmenname
Biovie Inc
Sektor
Branche
Telefon
775-888-3162
Adresse
680 W NYE LANE, CARSON CITY
Vergleichen Sie BIVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
8.19 | 12.98M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Eingeleitet | B. Riley Securities | Buy |
Biovie Inc Aktie (BIVI) Neueste Nachrichten
What drives BioVie Inc. stock priceTriple-digit growth rates - Autocar Professional
BioVie Inc. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com
BioVie appoints Amy Chappell, Kameel Farag to board of directors - TipRanks
BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative
What analysts say about BioVie Inc. stockExceptional trading results - jammulinksnews.com
Is BioVie Inc. a good long term investmentMarket-crushing stock picks - jammulinksnews.com
New to The Street Episode #679 Airs Tonight on Fox Business Network - New Castle News
What makes BioVie Inc. stock price move sharplyFree Consultation - beatles.ru
How high can BioVie Inc. stock price go in 2025Free Stock Market Practical Discussion Forums - beatles.ru
Why BioVie Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser
How BioVie Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability - The Des Moines Register
BioVie Inc. Presents Promising Data on Bezisterim's Effects on Aging and Neurodegeneration at World Aging and Rejuvenation Conference - Nasdaq
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference - The Manila Times
Breakthrough Alzheimer's Drug Shows Unprecedented 4-Year Biological Age Reversal in Phase 3 Trial - Stock Titan
BioVie (NASDAQ:BIVI) Stock Price Down 15.6% – Should You Sell? - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire
BioVie Announces 1-for-10 Reverse Stock Split - TipRanks
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Foster's Daily Democrat
BioVie (BIVI) Highlights Innovative Clinical Trial at Upcoming C - GuruFocus
New to The Street Show Number 675 Airing This Saturday on Bloomberg Television Featuring FLOKI, BioVie, Arrive AI, Health In Tech, and Commercialville T.V. - AInvest
BioVie announces poster on patient-centric accessibility of SUNRISE-PD trial - TipRanks
Revolutionary Parkinson's Trial Brings Treatment Testing to Patients' HomesSee How It Works - Stock Titan
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Ad - GuruFocus
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at - GlobeNewswire
BioVie Approves Reverse Stock Split Authority - TipRanks
New to The Street’s Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Oklahoman
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - ACCESS Newswire
BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lubbock Avalanche-Journal
Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World
Millennium Management LLC Acquires Shares of 122,619 BioVie Inc. (NASDAQ:BIVI) - Defense World
Squarepoint Ops LLC Invests $28,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in BioVie LawsuitBIVI - ACCESS Newswire
Finanzdaten der Biovie Inc-Aktie (BIVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):